Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-07-25

FDA Approved: FETZIMA — Original Application (Allergan, Inc.)

View source ↗

Summary

FDA approved FETZIMA (levomilnacipran hydrochloride) as a new prescription antidepressant for the treatment of major depressive disorder following Allergan's or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FETZIMA (levomilnacipran hydrochloride)

Snippet

ORIG AP for FETZIMA (LEVOMILNACIPRAN HYDROCHLORIDE)